Literature DB >> 3819097

Cutaneous sarcoidosis in Caucasians.

N K Veien, D Stahl, H Brodthagen.   

Abstract

One hundred eighty-eight Caucasian patients with cutaneous sarcoid lesions were studied prospectively. Twenty-five had erythema nodosum, while 163 had infiltrative cutaneous lesions. One hundred thirty-eight patients had systemic as well as cutaneous lesions, and fifty had cutaneous lesions only. All types of clinical lesions were seen among patients with cutaneous lesions only. The extent of cutaneous lesions did not correlate with the extent of systemic disease. Papular lesions were relatively uncommon and occurred as the only manifestation of the disease or were associated with hilar adenopathy and acute disease. Lupus pernio, scar infiltrates, and plaque lesions were the most common clinical lesions and were typically chronic and commonly associated with pulmonary mottling and/or fibrosis. Forty-eight of 127 had a histologically positive Kveim test. Among patients followed for more than 2 years, dinitrochlorobenzene (DNCB) sensitivity was higher among those with acute disease than among those with chronic disease. Seventy-nine patients with infiltrative cutaneous lesions were followed until the cutaneous lesions had healed. Those with lupus pernio were often left with unsightly telangiectatic scars, while the other types of lesions left either pale, slightly depressed scars or no scars at all.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819097     DOI: 10.1016/s0190-9622(87)70070-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  16 in total

1.  Hair loss and plaquelike skin lesions.

Authors:  J C Cather; M A Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-01

2.  Nail Sarcoidosis Presenting with Longitudinal Erythronychia.

Authors:  Paula P M van Lümig; Marcel C Pasch
Journal:  Skin Appendage Disord       Date:  2017-11-09

Review 3.  Cutaneous sarcoidosis.

Authors:  N J Wilson; C M King
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

4.  Nail Sarcoidosis with and without Systemic Involvement: Report of Two Cases.

Authors:  Leandro Noriega; Paulo Criado; Tatiana Gabbi; João Avancini; Nilton Di Chiacchio
Journal:  Skin Appendage Disord       Date:  2015-07-10

5.  The lady with the dragon tattoo.

Authors:  S L O'Beirne; D N O'Dwyer; S M Walsh; J D Dodd; T B Crotty; S C Donnelly
Journal:  Ir J Med Sci       Date:  2016-03-09       Impact factor: 1.568

Review 6.  Cutaneous Granulomatosis: a Comprehensive Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Carlo Mainetti; Marie-Astrid Peeters; Emmanuel Laffitte
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 7.  Sarcoidosis and molecular mimicry--important etiopathogenetic aspects: current state and future directions.

Authors:  Georgi Tchernev; Julian Ananiev; José Carlos Cardoso; Uwe Wollina; Shyam B Verma; James W Patterson; Lyubomir A Dourmishev; Michael Tronnier; Hiroyuki Okamoto; Kana Mizuno; Nobuo Kanazawa; Maya Gulubova; Irena Manolova; Cristina Salaro
Journal:  Wien Klin Wochenschr       Date:  2012-04-14       Impact factor: 1.704

Review 8.  Atypical Cutaneous Presentations of Sarcoidosis: Two Case Reports and Review of the Literature.

Authors:  David L Leverenz; Christopher Henderson; Ankoor Shah
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-14       Impact factor: 4.806

9.  Subcutaneous sarcoidosis: a clinical analysis of nine patients.

Authors:  Masaru Ando; Eishi Miyazaki; Yutaka Hatano; Suehiro Nishio; Chihiro Torigoe; Mari Yamasue; Yutaka Mukai; Shin-Ichi Nureki; Jun-Ichi Kadota
Journal:  Clin Rheumatol       Date:  2016-07-23       Impact factor: 2.980

Review 10.  Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature.

Authors:  Ali Nawras; Mohammad M Alsolaiman; Shahid Mehboob; Catherine Bartholomew; Benedict Maliakkal
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.